Low back pain (LBP) is often described as pain or discomfort localized between the lower rib margins and the gluteal folds, with or without symptoms extending into the legs (
1,
2). Typically, a variety of non-surgical options are recommended to manage lumbosacral radicular pain, including lifestyle modifications, physical therapy, exercise, oral or local analgesics, and epidural steroid injections (ESIs) (
3,
4). The primary objective of these conservative strategies is to delay or prevent the necessity for surgery (
5,
6). The ESIs are minimally invasive treatments that are extensively used and have been demonstrated to be effective in reducing lumbosacral radicular pain. In addition, they alleviate acute lower back and leg pain by administering corticosteroids into the epidural space through caudal, interlaminar, or transforaminal techniques, frequently in conjunction with local anesthetics (
7). Among the most frequently employed interventions for chronic spinal pain are epidural corticosteroid injections. They alleviate pain by reducing inflammatory mediators, reducing vascular permeability, and minimizing C fiber injury (
8). The efficacy of local anesthetics administered through epidural injection has been demonstrated in numerous studies, particularly in patients with elevated cerebrospinal fluid protein levels, a marker frequently associated with inflammation (
9). Epidural injections continue to be a key tool in pain management, and new technologies have made these procedures even more precise and effective. One such innovation is the Racz catheter epidural adhesiolysis, which helps target medication delivery more accurately and breaks down scar tissue that might be contributing to a patient’s pain (
10).